Total Payments
$187,434
2024 Payments
$147,067
Companies
27
Transactions
296
Medicare Patients
2,512
Medicare Billing
$361,523
Payment Breakdown by Category
Other$110,550 (59.0%)
Research$60,141 (32.1%)
Travel$9,192 (4.9%)
Food & Beverage$7,450 (4.0%)
Education$99.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $110,050 | 23 | 58.7% |
| Unspecified | $60,141 | 1 | 32.1% |
| Travel and Lodging | $9,192 | 63 | 4.9% |
| Food and Beverage | $7,450 | 207 | 4.0% |
| Honoraria | $500.00 | 1 | 0.3% |
| Education | $99.99 | 1 | 0.1% |
Payments by Type
General
$127,293
295 transactions
Research
$60,141
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $182,110 | 134 | $0 (2024) |
| ABBVIE INC. | $1,160 | 43 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $588.19 | 19 | $0 (2024) |
| Shire North American Group Inc | $530.49 | 10 | $0 (2019) |
| Cynosure, Inc | $500.00 | 1 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $464.27 | 10 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $265.39 | 14 | $0 (2023) |
| Allergan, Inc. | $254.46 | 15 | $0 (2022) |
| Horizon Therapeutics plc | $195.84 | 6 | $0 (2023) |
| Alcon Vision LLC | $178.12 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147,067 | 135 | Bausch & Lomb Americas Inc. ($146,536) |
| 2023 | $36,523 | 50 | Bausch & Lomb Americas Inc. ($35,543) |
| 2022 | $1,272 | 43 | ABBVIE INC. ($366.14) |
| 2021 | $443.20 | 14 | Mallinckrodt Hospital Products Inc. ($145.25) |
| 2020 | $75.67 | 4 | Novartis Pharmaceuticals Corporation ($43.55) |
| 2019 | $647.07 | 21 | Shire North American Group Inc ($292.87) |
| 2018 | $422.87 | 9 | Bausch & Lomb, a division of Bausch Health US, LLC ($182.68) |
| 2017 | $981.78 | 20 | Cynosure, Inc ($500.00) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: EYE CARE | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $123.78 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $70.32 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $48.32 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $777.49 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $516.96 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $141.51 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $134.25 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $59.58 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $49.18 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $41.39 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $40.81 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: EYE CARE | ||||||
| 11/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $1,154.90 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Single-Center Randomized Double-Masked Placebo Controlled Parallel-Group, Study of the Effects and Safety of 5% lifitegrast Ophthalmic Solution in Subjects with Dry Eye Disease in Ocular Graft-versus- Host Disease | Bausch & Lomb Americas Inc. | $60,141 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 676 | 987 | $400,412 | $99,798 |
| 2022 | 12 | 678 | 1,025 | $410,640 | $101,920 |
| 2021 | 14 | 706 | 1,038 | $369,570 | $110,036 |
| 2020 | 7 | 452 | 744 | $162,540 | $49,769 |
Total Patients
2,512
Total Services
3,794
Medicare Billing
$361,523
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 403 | $76,570 | $26,616 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 176 | $49,280 | $15,176 | 30.8% |
| 68760 | Repair tear duct opening by heat, tying, or laser surgery | Office | 2023 | 37 | 45 | $37,140 | $10,759 | 29.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 15 | 21 | $28,770 | $9,067 | 31.5% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 11 | 13 | $72,602 | $7,666 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $18,550 | $6,100 | 32.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 39 | 39 | $29,493 | $5,597 | 19.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 42 | 44 | $23,441 | $4,967 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 62 | $16,414 | $4,798 | 29.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 21 | 22 | $12,160 | $3,465 | 28.5% |
| 68761 | Closure of tear duct opening using plug | Facility | 2023 | 20 | 22 | $26,142 | $2,444 | 9.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 23 | 26 | $3,640 | $1,149 | 31.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 36 | 42 | $3,360 | $1,014 | 30.2% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2023 | 16 | 19 | $2,850 | $979.74 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 435 | $81,550 | $29,777 | 36.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 27 | 38 | $103,266 | $16,545 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 136 | $37,060 | $11,953 | 32.3% |
| 68760 | Repair tear duct opening by heat, tying, or laser surgery | Office | 2022 | 39 | 46 | $31,980 | $10,938 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $17,106 | $6,018 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 46 | 52 | $26,784 | $5,909 | 22.1% |
| 68761 | Closure of tear duct opening using plug | Facility | 2022 | 26 | 57 | $58,302 | $5,410 | 9.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 32 | 32 | $18,798 | $4,350 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 47 | $12,028 | $3,625 | 30.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 17 | 21 | $10,740 | $3,294 | 30.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 33 | 37 | $5,549 | $1,678 | 30.2% |
About Dr. Richard Yee, MD
Dr. Richard Yee, MD is a Ophthalmology healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205817764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Yee, MD has received a total of $187,434 in payments from pharmaceutical and medical device companies, with $147,067 received in 2024. These payments were reported across 296 transactions from 27 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($110,050).
As a Medicare-enrolled provider, Yee has provided services to 2,512 Medicare beneficiaries, totaling 3,794 services with total Medicare billing of $361,523. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Bellaire, TX
- Active Since 11/10/2005
- Last Updated 01/28/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205817764
Products in Payments
- MIEBO (Drug) $121,045
- XIIDRA (Drug) $60,931
- BLINK NUTRITEARS (Drug) $850.00
- DURYSTA (Drug) $838.39
- ACTHAR (Biological) $616.49
- Surgitron (Device) $500.00
- VYZULTA (Drug) $403.56
- VUITY (Drug) $318.19
- TEPEZZA (Drug) $195.84
- PROKERA (Device) $143.40
- TEARCARE SYSTEM (Device) $143.24
- RESTASIS (Drug) $140.13
- rocklatan (Drug) $125.00
- OXERVATE (Drug) $110.44
- Avenova (Device) $76.10
- LUMIGAN (Drug) $66.95
- Cequa (Drug) $60.52
- rhopressa (Drug) $57.13
- CRYSTALENS (Device) $56.97
- TEPEZZA (Biological) $56.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bellaire
Otis Walton, Md, MD
Ophthalmology — Payments: $319,174
Ophthalmology $319,174
Dr. Ting Fang-Suarez, M.d, M.D
Ophthalmology — Payments: $116,705
Ophthalmology $116,705
Prethy Rao, Md, MD
Ophthalmology — Payments: $52,342
Ophthalmology $52,342
Dr. Kenneth Fan, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $22,226
Ophthalmology $22,226
Dr. Edward Wade, M. D, M. D
Ophthalmology — Payments: $14,740
Ophthalmology $14,740
Geoffrey Collett, Md, MD
Ophthalmology — Payments: $11,963
Ophthalmology $11,963